128 related articles for article (PubMed ID: 10072506)
1. Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.
Kayagaki N; Yamaguchi N; Nakayama M; Kawasaki A; Akiba H; Okumura K; Yagita H
J Immunol; 1999 Mar; 162(5):2639-47. PubMed ID: 10072506
[TBL] [Abstract][Full Text] [Related]
2. Human small intestinal mucosa harbours a small population of cytolytically active CD8+ alphabeta T lymphocytes.
Melgar S; Bas A; Hammarström S; Hammarström ML
Immunology; 2002 Aug; 106(4):476-85. PubMed ID: 12153510
[TBL] [Abstract][Full Text] [Related]
3. Egr family members regulate nonlymphoid expression of Fas ligand, TRAIL, and tumor necrosis factor during immune responses.
Droin NM; Pinkoski MJ; Dejardin E; Green DR
Mol Cell Biol; 2003 Nov; 23(21):7638-47. PubMed ID: 14560009
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-related apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes.
Simon AK; Williams O; Mongkolsapaya J; Jin B; Xu XN; Walczak H; Screaton GR
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5158-63. PubMed ID: 11309507
[TBL] [Abstract][Full Text] [Related]
5. T-cell-mediated lysis of B cells induced by a CD19xCD3 bispecific single-chain antibody is perforin dependent and death receptor independent.
Gruen M; Bommert K; Bargou RC
Cancer Immunol Immunother; 2004 Jul; 53(7):625-32. PubMed ID: 15175907
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection. TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection.
Katsikis PD; Garcia-Ojeda ME; Torres-Roca JF; Tijoe IM; Smith CA; Herzenberg LA; Herzenberg LA
J Exp Med; 1997 Oct; 186(8):1365-72. PubMed ID: 9334376
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.
Song K; Chen Y; Göke R; Wilmen A; Seidel C; Göke A; Hilliard B; Chen Y
J Exp Med; 2000 Apr; 191(7):1095-104. PubMed ID: 10748228
[TBL] [Abstract][Full Text] [Related]
8. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.
Lum JJ; Pilon AA; Sanchez-Dardon J; Phenix BN; Kim JE; Mihowich J; Jamison K; Hawley-Foss N; Lynch DH; Badley AD
J Virol; 2001 Nov; 75(22):11128-36. PubMed ID: 11602752
[TBL] [Abstract][Full Text] [Related]
9. Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells.
Shi J; Ikeda K; Fujii N; Kondo E; Shinagawa K; Ishimaru F; Kaneda K; Tanimoto M; Li X; Pu Q
Cancer Sci; 2005 Feb; 96(2):127-33. PubMed ID: 15723658
[TBL] [Abstract][Full Text] [Related]
10. Both HIV-Infected and Uninfected Cells Express TRAILshort, Which Confers TRAIL Resistance upon Bystander Cells within the Microenvironment.
Nie Z; Aboulnasr F; Natesampillai S; Burke SP; Krogman A; Bren GD; Chung TDY; Anderson JR; Smart MK; Katzmann DJ; Rajagopalan G; Cummins NW; Badley AD
J Immunol; 2018 Feb; 200(3):1110-1123. PubMed ID: 29263214
[TBL] [Abstract][Full Text] [Related]
11. Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury.
Zhao D; Yang L; Han P; Zhang H; Wang F; Meng Z; Gan H; Wu Z; Sun W; Chen C; Dou G; Gu R
Front Pharmacol; 2023; 14():1171293. PubMed ID: 37274104
[TBL] [Abstract][Full Text] [Related]
12. Exosomal delivery of TRAIL and miR‑335 for the treatment of hepatocellular carcinoma (Review).
Thapa N; Chwae YJ; Yoo KH; Won TB; Kang D; Choi D; Kim J
Int J Mol Med; 2023 Jan; 51(1):. PubMed ID: 36416311
[TBL] [Abstract][Full Text] [Related]
13. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection.
Carreca AP; Gaetani M; Busà R; Francipane MG; Gulotta MR; Perricone U; Iannolo G; Russelli G; Carcione C; Conaldi PG; Badami E
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891518
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.
Dadey RE; Grebinoski S; Zhang Q; Brunazzi EA; Burton A; Workman CJ; Vignali DAA
Immunohorizons; 2021 Jan; 5(1):48-58. PubMed ID: 33483333
[TBL] [Abstract][Full Text] [Related]
15. PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity.
Piazza GA; Ward A; Chen X; Maxuitenko Y; Coley A; Aboelella NS; Buchsbaum DJ; Boyd MR; Keeton AB; Zhou G
Drug Discov Today; 2020 Aug; 25(8):1521-1527. PubMed ID: 32562844
[TBL] [Abstract][Full Text] [Related]
16. The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses.
Sag D; Ayyildiz ZO; Gunalp S; Wingender G
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31574961
[TBL] [Abstract][Full Text] [Related]
17. Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy.
Naval J; de Miguel D; Gallego-Lleyda A; Anel A; Martinez-Lostao L
Cancers (Basel); 2019 Mar; 11(4):. PubMed ID: 30934872
[TBL] [Abstract][Full Text] [Related]
18. Many Th Cell Subsets Have Fas Ligand-Dependent Cytotoxic Potential.
Kotov DI; Kotov JA; Goldberg MF; Jenkins MK
J Immunol; 2018 Mar; 200(6):2004-2012. PubMed ID: 29436413
[TBL] [Abstract][Full Text] [Related]
19. Old game, new players: Linking classical theories to new trends in transplant immunology.
da Silva MB; da Cunha FF; Terra FF; Camara NO
World J Transplant; 2017 Feb; 7(1):1-25. PubMed ID: 28280691
[TBL] [Abstract][Full Text] [Related]
20. Onto better TRAILs for cancer treatment.
de Miguel D; Lemke J; Anel A; Walczak H; Martinez-Lostao L
Cell Death Differ; 2016 May; 23(5):733-47. PubMed ID: 26943322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
